PAX6 and neoplasm: Moreover, combining 5‐Aza with CDK4/6i resulted in greater inhibition of AGS‐PAX6 tumor growth in mice than the single 5‐Aza treated group or CDK4/6i treated group, and this effect was augmented in the AGS‐vector group (Figures 6L–6N).